Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy HIMS $LLY $NVO The FDA will discuss 7 peptides for possible inclusion on the 503A Bulks List on July 23 24: BPC 157 KPV TB 500 MOTs C Emideltide Semax This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026)